妊娠合并先天性心脏病伴肺动脉高压孕妇的母婴结局
胡思宇, 金镇中国医科大学附属盛京医院妇产科, 沈阳 110004
收稿日期:
2021-09-22出版日期:
2022-07-30发布日期:
2022-06-27通讯作者:
金镇E-mail:jinzhen66@aliyun.com作者简介:
胡思宇(1996-),女,医师,硕士研究生.关键词: 肺动脉高压, 妊娠, 先天性心脏病, 主要心血管不良事件, B型利钠肽, 肌酸激酶同工酶
Abstract: Objective To explore the maternal and neonatal outcomes of pulmonary arterial hypertension-associated congenital heart disease (PAH-CHD) and to analyze independent risk factors for critical major adverse cardiovascular events (MACEs). Methods Fifty-five pregnant women with PAH-CHD (31.4±4.6 years) who were treated at the Shengjing Hospital of China Medical University were recruited to this study. The chi-square test was used to compare the patients' basic clinical information characteristics,grading of pulmonary hypertension and cardiac function,and maternal and infant outcomes. Logistic regression was used to further analyze independent risk factors for critical MACE. Results We found significant differences in the grading of pulmonary arterial hypertension,gestational age of pregnancy termination,anesthesia method,incidence of MACE,and neonatal complications among groups (P< 0.05). Pulmonary artery pressure,B-type natriuretic peptide (BNP),and creatine kinase isoenzyme (CK-MB) were independent risk factors for critical MACE. Conclusion The morbidity and mortality of pregnant women with PAH-CHD are very high. Multidisciplinary treatment and management are extremely important to both maternal and fetal health. Pulmonary artery pressure,BNP,and CK-MB may play an important role in guiding clinical treatment and prognosis.
Key words: pulmonary arterial hypertension, pregnancy, congenital heart disease, major adverse cardiac event, brain natriuretic peptide, creatine kinase isoenzyme
PDF全文下载地址:
https://journal.cmu.edu.cn/CN/article/downloadArticleFile.do?attachType=PDF&id=3034